GlassScriptPhysician profile
Sean Daniel Odell
NPI 1518981612
$7,896.15
in general payments reported to CMS, 2019-2025
21 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $2,105 · 2021: $143 · 2022: $119 · 2023: $2,528 · 2024: $821 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,964 · Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,964.11 |
| Food and Beverage | $1,412.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,444.51 | 2020-2025 | Mako |
| Arthrex, INC. | $1,386.30 | 2019-2024 | Arthrex |
| Smith+Nephew, INC. | $710.50 | 2025 | K-15 Pork, Pico 14 |
| Oak Med, INC. | $289.87 | 2024-2025 | |
| Avanos Medical | $173.13 | 2022-2024 | Trivisc Sodium Hyaluronate, Genvisc 850 Sodium Hyaluronate |
| Ferring Pharmaceuticals INC. | $146.08 | 2021-2025 | Euflexxa |
| Heron Therapeutics, INC. | $103.96 | 2024-2025 | Zynrelef |
| Pajunk Medical Systems, LP | $95.70 | 2019 | |
| Orthofix Medical, INC. | $80.18 | 2023-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $75.33 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $67.43 | 2023-2025 | Exparel, Iovera, Zilretta |
| Bioventus LLC | $66.45 | 2021-2025 | Gelsyn-3 |
| Vertex Pharmaceuticals Incorporated | $65.88 | 2024-2025 | |
| Medwest Associates | $41.65 | 2021-2023 | |
| Ethicon US, LLC | $39.25 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $22.93 | 2019 | |
| Orthogenrx INC. | $21.92 | 2021 | |
| Davol INC. | $19.40 | 2023 | |
| Fidia Pharma USA INC. | $16.59 | 2021 | |
| Zimvie INC. | $14.85 | 2023 | |
| Ibsa Pharma INC. | $14.24 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Odell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.